⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Novo Nordisk A/S - share repurchase programme
globenewswire.com
NVO
Neo Launches with $100M to Secure AI Software Across the Enterprise
globenewswire.com
S
PANW
SHOP
NVDA
MSFT
GOOG
AMZN
CRM
ADBE
IBM
INTC
AMD
QCOM
META
TWLO
LI
CVNA
DDOG
CRWD
OKTA
PLTR
SNOW
SMCI
MU
AMAT
LRCX
ASML
ORCL
SAP
CSCO
FTNT
CHKP
VRTX
REGN
GILD
BIIB
AZN
PFE
MRNA
BMY
AMGN
LLY
ABBV
NVO
SNPS
CDNS
MCHP
NXPI
ON
ADI
TXN
CRSP
EXAS
ALGN
TDOC
ROKU
COIN
PYPL
HOOD
Catching Cancer Earlier, One Breath at a Time: SpotitEarly Partners with HITLAB to Accelerate Its U.S. Launch
businesswire.com
JNJ
PFE
LLY
NVO
MSFT
AMZN
MEDIA INVITE: A Conversation on Bias and Lived Experience
prnewswire.com
LLY
NVO
BG
AMGN
MDGL
RGP
PFE
REGN
WVE
ZETA
BSX
Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved
globenewswire.com
NVO
Tuberculosis Clinical Trial Pipeline Shows Potential with Active Contributions from 28+ Key Companies | DelveInsight
globenewswire.com
FMS
BIIB
MDT
NVO
LLY
AZN
RDNT
LXRX
SNY
XRTX
RGEN
Inductive Bio Wins 3rd Consecutive AI Drug Discovery Benchmark
prnewswire.com
INDB
MRK
NVO
AMGN
HUYABIO International Delivers Significant Landmark Phase 3 Results in Advanced Melanoma
prnewswire.com
NVO
Advancements in CKD Care: How New Therapies from AstraZeneca, Johnson & Johnson, Novartis, Bayer, and Amgen Are Changing the Landscape
globenewswire.com
AMGN
AZN
JNJ
NVS
ABBV
AKBA
ARDX
CHNR
LLY
FGEN
GILD
GSK
NVO
PFE
Novo Nordisk A/S - share repurchase programme
globenewswire.com
NVO